期刊文献+

反义寡核苷酸对K562细胞的抑制作用及诱导细胞凋亡的研究 被引量:3

THE STUDY OF INHIBITORY AND APOPTOSIS OF K562 CELLS BY ANTISENSE OLIGODEOXYNUCLEOTIDES
下载PDF
导出
摘要 目的 :研究bcr abl硫代磷酸反义寡脱氧核糖核酸 (Aspo)作用于K5 62细胞后 ,对细胞mRNA、蛋白水平的影响 ,以及诱导细胞凋亡情况。方法 :Aspo与K5 62细胞共培养后 ,用流式细胞仪检测P2 10蛋白表达及细胞凋亡率 ,RT PCR半定量检测bcr ablmRNA表达情况 ,电镜观察细胞凋亡的形态学改变。结果 :K5 62细胞经浓度大于 5 μmol Lbcr ablAspo处理 2 4h ,流式细胞仪检测细胞P2 10蛋白表达下调甚至完全受抑制 ,10 μmol Lbcr ablAspo作用 48h ,细胞bcr ablmRNA下降 45 %左右 ,当细胞初始浓度为 1× 10 4 ml时 ,Aspo作用 12 0h细胞凋亡率 2 0 %~ 30 % ,当细胞数增加至 1× 10 5 ml时 ,Aspo作用 48h即可使 30 %细胞发生凋亡 ,电镜下观察到典型凋亡细胞形态学改变。结论 :bcr abl反义核酸对K5 62细胞mRNA水平具有抑制作用 。 Aim:To study the effect of bcr abl fusion gene antisense phosphorothioate oligodeoxynucleotide (Aspo) on bcr abl mRNA and apoptosis of K562 cells.Methods: Cells were exposed to Aspo.P210 was measured by Flow Cytometry.Cellular bcr abl mRNA was detected by RT PCR mediquantitive analysis.Cell apoptosis was measured by Flow Cytometry and observed by electron microscope (EM).Results:The P210 was down regulated or completely suppressed after 24h treatment with more than 5 μmol/L Aspo.The decrease of bcr abl mRNA was about 45%.After incubation 48 h with 10 μmol/L Aspo.Also,20%~30% K562 cells were induced to apoptosis at 120 h when the cell number was 1×10 4/ml at the beginning. While the cell number was 1×10 5/ml,the apoptosis rate was 30% after 48 h culture and the typical morphology of apoptosis cell was observed under EM.Conclusion:bcr abl Aspo could inhibit the expression of bcr abl mRNA and P210.Also,it could induce apoptosis of K562 cells.
出处 《中国应用生理学杂志》 CAS CSCD 北大核心 2001年第3期213-216,共4页 Chinese Journal of Applied Physiology
基金 福建省科委优先发展基金资助课题 (98 Z 2 13 )
关键词 反义寡核苷酸 BCR-ABL融合基因 K562细胞系 抑瘤作用 细胞凋亡 antisense oligodeoxynucleotides bcr abl fusion gene K562 cell line
  • 相关文献

参考文献6

  • 1[1]Shtivelman E,Lifashitz B,Gale R P,et al.Fused transcript of abl and bcr genes in chronic myelogeneous leukemia[J].Nature,1985,315:550-559.
  • 2[2]De Fabritiis P,Petti M C,Moutefusco E,et al.BCR/ABL antisense oligodeoxynucleotides in vitro purging and autolous bone marrow transplantation for pations with chronic myelogeneous leukemia in advanced phase[J].Blood,1998,91:3156-62.
  • 3[3]Ferraris M G.Antisense oligonucleotides[J].Hematologica, 1994;79:184-8.
  • 4[4]Bedi A,Zehnbauer B A,Barber J P,et al.Inhibitor of apoptosis by BCR-ABL in chronic myeloid leukemia[J].Blood,1994,83:2038-44.
  • 5[5]Bedi B A,Zehnbauer B A,Collector M I,et al.BCR/ABL gene rearrangement and expression of primitive hematopoietic progenitor in chronic myeloid leukemia[J].Blood,1993,81:2898-2902.
  • 6[6]Clarkson B D,Strife A,Wisniewski D,et al.New understanding of the pathogenesis of CML:a protype of early neoplasia[J].Leukemia,1997,11:1404-28.

同被引文献52

  • 1戴木水,罗绍凯,戴丽君,洪文德,彭爱华.反义 bcr/abl 寡核苷酸诱导 K562 细胞凋亡的研究[J].中华血液学杂志,1997,18(5):264-265. 被引量:6
  • 2Lara W, Heiko van der K, Cornelius M, et al. Inhibition of BCR-ABL gene expression by small interfering RNA sensitizes for imatinib mesylate ( STI571 ) [ J ]. BLOOD, 2003,102 : 2236- 2239.
  • 3Monika W, Uta F, Wilhelm W, et al. Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference(RNAi) [J].Oncogene,2002,21 : 5716 - 5724.
  • 4Dimitri S, Leigh F, Aparna S, et al. Specificity of short interfering RNA determined through gene expression signatures [ J ].PNAS, 2003,5 : 6347 - 6352.
  • 5Salgia R,Li JL,Ewaniuk DS,Pear W,Pisick E,Burky SA,Ernst T,Sattler M,Chen LB,Griffin JD(1997)bcr/abl induces multiple abnormalities of cytoskeletalfunction[J].J Clin lnvest 100∶46~57.
  • 6Chopra R,Pu QQ and Elefanty AG.Biology of bcr/abl[J].Blood Reviews,1999,13∶211~229.
  • 7Daley GQ,Baltimore D(1988)Transformation of an interleukin-3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210 bcr/abl protein.Proc Natl Acad Sci USA 85∶9312~9316.
  • 8Afar DEH,Goga A,McLaughlin J,Witte ON,Sawyers CL(1994)Differential Complementation of bcr/abl point mutants with c-MYC[J].Science 264∶424~426.
  • 9Jong R de,Hoeve J ten,Heisterkamp N,Groffen J(1995)Crkl is complexed with tyrosine-phosphorylated Cb1 in Ph-positive leukemia[J].J Biol Chem 270∶21468~21471.
  • 10Heisterkamp N,Jong R de,Groffen J(1997)Altered signalling in bcr/abl caused leukemias(abstract)[J].J Mol Med 75∶B249.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部